Development code · Small Molecule
PNU-165442G
PNU-165442G is a development code for AXS-14 (esreboxetine), developed by Axsome Therapeutics, Inc..
- Status
- Phase 3 for Fibromyalgia
- Mechanism
- NET Reuptake inhibitor
- Developer
- Axsome Therapeutics, Inc.
Programs
- AXS-14 (esreboxetine) for FibromyalgiaPhase 3Recruiting
Also known as
- AXS-14
- (S,S)-reboxetine
- 98819-76-2
- esreboxetine